Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000226789

Medchemexpress LLC 3-(cyclopropylmethoxy)-4-(difluoromethoxy)-N-isopropylbenzamide | 1917347-65-9 | 99.8% | 299.31 g·mol⁻¹ | C15H19F2NO3 | 100 MG
SDP

Catalog No. 5000226789
Encompass_Preferred

FCPR03 is a small-molecule research compound that functions as a potent and selective phosphodiesterase 4 (PDE4) inhibitor. It is provided for laboratory research use and supplied in solid and solution formats for experimental flexibility.

  • Potent, selective PDE4 inhibitor with reported low-nanomolar IC50 values.
  • High purity (~99.8%) suitable for in vitro studies.
  • Molecular weight 299.31 g·mol⁻¹; molecular formula C15H19F2NO3.
  • Available as a 100 mg solid and as 10 mM DMSO solutions for convenient dosing.
  • Intended for research use only; not for human or clinical use.

Catalog No. 50-002-26789 Supplier Medchemexpress LLC Supplier No. HY117977100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

FCPR03 is a small-molecule research compound that functions as a potent and selective phosphodiesterase 4 (PDE4) inhibitor. It is provided for laboratory research use and supplied in solid and solution formats for experimental flexibility.

  • Potent, selective PDE4 inhibitor with reported low-nanomolar IC50 values.
  • High purity (~99.8%) suitable for in vitro studies.
  • Molecular weight 299.31 g·mol⁻¹; molecular formula C15H19F2NO3.
  • Available as a 100 mg solid and as 10 mM DMSO solutions for convenient dosing.
  • Intended for research use only; not for human or clinical use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.